Dcoa-Diabetes Research Foundation Inc is categorized under Diabetes Doctors in Houston, TX and active since 2005.
Dcoa-Diabetes Research Foundation Inc was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Diabetes Doctors business, which does work in the B2C market, and is classified as a Diabetes Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Kimon J Angelides at the company’s single location by writing to 11301 Fllbrook Drive # 100, Houston, Texas TX 77065 or by phoning (281) 897-9900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Dcoa-Diabetes Research Foundation Inc |
| Contact Person: | Kimon J Angelides |
| Address: | 11301 Fllbrook Drive # 100, Houston, Texas 77065 |
| Phone Number: | (281) 897-9900 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Diabetes Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Dcoa-Diabetes Research Foundation Inc was started in 2005 to provide professional Diabetes Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Kimon J Angelides for inquiries that concern Dcoa-Diabetes Research Foundation Inc by calling the company number (281) 897-9900, as your correspondence is most welcome. Additionally, the physical location of the single location of Dcoa-Diabetes Research Foundation Inc can be found at the coordinates as well as the street address 11301 Fllbrook Drive # 100 in Houston, Texas 77065.
For its online presence, you may visit Dcoa-Diabetes Research Foundation Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.